Mesoblast Ltd., of Melbourne, Australia, appointed Bill Burns vice chairman of the board. Burns was CEO of Roche Pharmaceuticals from 2001 to 2009, and in October 2014, he was appointed a trustee of the Institute of Cancer Research, London. Burns has served on Mesoblast's board since 2014.